Skip to main content
28-03-2024 Stroke News

Dual antiplatelet therapy reduces neurological deterioration in stroke

Treating patients with acute mild-to-moderate stroke with aspirin plus clopidogrel reduces the risk for early neurological deterioration at 7 days, compared with aspirin alone.

Implantable monitor for heart failure in DMD

Open Access Telemonitoring in Cardiology Case Study

Assessing heart failure progression in patients with Duchenne muscular dystrophy is challenging due to the multisystem nature of the disease. This is the first use of an implantable pulmonary artery pressure monitor.

High risk patients: new onset AF complicating MI

Free for a limited time Atrial Fibrillation Review

Atrial fibrillation and myocardial infarction often coexist, leading to to increased morbidity and need for comprehensive risk management strategies. What's the best clinical approach for these patients?

Glymphatic system in migraine and other headaches

Open Access Migraine Review

Impairment of the glymphatic system is implicated in numerous neurological disorders, including Alzheimer’s disease, stroke, and sleep disturbances. Does it also play a role in migraine pathogenesis?

Using combined PET-MRI to diagnose autoimmune limbic encephalitis

Open Access Autoimmune Encephalitis Case Study

In the most common subtypes of autoimmune limbic encephalitis, existing biomarkers often display unspecific and subtle changes. But [18F]DPA-714-PET-MRI shows potential as a direct imaging marker of neuroinflammation.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Live Webinar | 02-05-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on sleep in brain health

Live: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Dr. Rolf Fronczek
Dr. Renata Riha
Developed by: Springer Medicine

Implantable monitor for heart failure in DMD

Open Access Telemonitoring in Cardiology Case Study

Assessing heart failure progression in patients with Duchenne muscular dystrophy is challenging due to the multisystem nature of the disease. This is the first use of an implantable pulmonary artery pressure monitor.

Using combined PET-MRI to diagnose autoimmune limbic encephalitis

Open Access Autoimmune Encephalitis Case Study

In the most common subtypes of autoimmune limbic encephalitis, existing biomarkers often display unspecific and subtle changes. But [18F]DPA-714-PET-MRI shows potential as a direct imaging marker of neuroinflammation.

Nonketotic hyperglycemia hemichorea-hemiballismus

Open Access Type 2 Diabetes Case Study

HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.

Current Reviews

Utility of ganglion cells for the evaluation of anterior visual pathway pathology: a review

Optic Neuritis Review article

The management of optic neuropathy is fundamental to neuro-ophthalmic practice. Following the invention of the ophthalmoscope, clinicians, for a century or more, relied upon fundus examination in the evaluation of optic neuropathy. However, the …

Arterial spin labelling magnetic resonance imaging and perfusion patterns in neurocognitive and other mental disorders: a systematic review

Open Access Alzheimer's Disease Review

We reviewed 33 original research studies assessing brain perfusion, using consensus guidelines from a “white paper” issued by the International Society for Magnetic Resonance in Medicine Perfusion Study Group and the European Cooperation in …

Exosomal microRNAs in Parkinson’s disease: insights into biomarker potential and disease pathology

Parkinson's Disease Review Article

Parkinson’s disease (PD) is a prevalent neurodegenerative condition primarily affecting the elderly population. Despite its high incidence in aged individuals, there are no reliable blood-based biomarkers for clinical diagnosis of PD and early …

Glioblastoma stem cell metabolism and immunity

Despite enormous efforts being invested in the development of novel therapies for brain malignancies, there remains a dire need for effective treatments, particularly for pediatric glioblastomas. Their poor prognosis has been attributed to the …

Alzheimer's Disease Independent Medical Education

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by: Lilly

Developed by: Springer Healthcare IME

News | Vodcasts | Podcasts (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Emerging biomarkers and disease-modifying therapies for Alzheimer’s disease promise significant changes in how the condition is diagnosed and managed.

Guide yourself through this transition with our education program, led by world renowned experts and covering the biggest international conferences.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Webinar (Link opens in a new window)

Interact with experts from established amyloidosis centers who can offer you specialized guidance to support your mission to set up a local center. Network with other HCPs in your locality to discuss region-specific challenges in establishing amyloidosis centers. 

Supported by:
  • AstraZeneca and Alexion

Webcast | eLearning | Infographic (Link opens in a new window)

PET biomarkers are fast becoming critical in the new era of disease modification for Alzheimer’s disease. Techniques around amyloid and tau require the expertise of nuclear medicine and radiology physicians to investigate and interpret PET scans in clinical settings. This program examines current and emerging biomarkers and assists in identifying patterns from different PET tracers in an interactive perceptual learning environment.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Alzheimer's Disease Independent Medical Education

Neuroimaging for Alzheimer’s disease: eLearning (Link opens in a new window)

Neuroimaging plays an ever more critical role in clinical practice. PET Pearls is an interactive activity designed to improve your confidence and accuracy when interpreting imaging for early signs of cognitive impairment.

Supported by: Lilly

Developed by: Springer Healthcare IME

Further Reading

Arterial spin labelling magnetic resonance imaging and perfusion patterns in neurocognitive and other mental disorders: a systematic review

Open Access Alzheimer's Disease Review

We reviewed 33 original research studies assessing brain perfusion, using consensus guidelines from a “white paper” issued by the International Society for Magnetic Resonance in Medicine Perfusion Study Group and the European Cooperation in …

Mid- and long-term results of open repair for chronic type B aortic dissection in endovascular era

Open Access Aortic Dissection Original Article

Medical management is the standard treatment of chronic type B aortic dissection (CTBAD). However, the roles of open surgical repair (OSR) and thoracic endovascular repair (TEVAR) in patients with CTBAD remain controversial. Thus, this study aimed …

Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury

Open Access Multiple Sclerosis Original Research

Over the past decades, the phenotypes of relapsing–remitting and primary progressive multiple sclerosis (MS) have been intensively studied [ 1 ]. More recently, several attempts have been made to identify a subgroup of patients with a particularly …

Acute treatment of migraine: quantifying the unmet need through real-world data in Italy

Open Access Triptan Drugs Original Article

Migraine is a common neurological disorder whose onset is usually in adolescence or early adult life [ 1 ] and presents with symptoms which affect people’s quality of life limiting their participation in work, family, and social activities [ 2 ].

Related topics

In the most common subtypes of autoimmune limbic encephalitis, existing biomarkers often display unspecific and subtle changes. But [18F]DPA-714-PET-MRI shows potential as a direct imaging marker of neuroinflammation.

Read more

Impairment of the glymphatic system is implicated in numerous neurological disorders, including Alzheimer’s disease, stroke, and sleep disturbances. Does it also play a role in migraine pathogenesis?

Read more